The Validity and Reliability Study of the Chelsea Critical Care Physical Assesment Tool

The Validity and Reliability of the Turkish Version of the Chelsea Critical Care Physical Assesment Tool

This study is aimed at providing an translation and cross-cultural adaptation of Chelsea Critical Care Physical Assesment Tool (CPAx) and tested its reliability and validity.

Study Overview

• Status: Completed
• Conditions: ICU Patients; ICU Acquired Weakness
• Intervention / Treatment: Other: Validation of the Chelsea Critical Care Physical Assesment Tools

Detailed Description

Survival has increased in the ICU due to technological developments , but physical disability after discharge has become an important problem. İntensive Care Unit Acquired Weakness(ICU-AW) is seen in most of the patients admitted in this unit. The biggest reasons for ICU-AW are; sepsis, multiple organ failure and prolonged mechanical ventilation. The use of measurement tools to evaluate disabilities during stay and after discharge in intensive care unit, is a subject that has been researched all over the world.. These measurement tools provide; monitoring and evaluation during the ICU admission and assessment efficacy of treatment in the unit. The Chelsea Critical Care Physical Assessment Tool(CPAX) has been shown to valid, reliable and to exhibited strong clinimetric properties. CPAx is a numerical measurement tool, rated according to the 6-point Guttman Scale, from complete dependence to independence and consist of ten physical function parameters. This study is aimed at providing an translation and cross-cultural adaptation of Chelsea Critical Care Physical Assesment Tool (CPAx) and tested its reliability and validity. The protocol includes a pre-test of the Turkish version on 10 patients, a final revision, and a validation on a sample of 40 İCU patients.

• Study Type: Observational
• Enrollment (Actual): 50

Contacts and Locations

Study Locations

• Turkey
  • İ̇stanbul, Turkey, 34415
    • Mehmet Burak Uyaroğlu

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 14 years to 81 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

ICU patients

Description

Inclusion Criteria:

• Older than 18 years
• Critical adult patients
• Patients who were hospitalized for more than 48 hours in an ICU

Exclusion Criteria:

• Unstable fracture
• Limb deformities and dysfunction
• Myasthenia gravis
• Neuromuscular dysfunction
• Patients who diagnosed COVİD-19

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Chelsea Critical Care Physical Assesment Tools	The Chelsea critical care physical assessment (CPAx) is a measurement tool used to assess physical function in the ICU. The Chelsea critical care physical assessment (CPAx) tool is an outcome measure designed to assess 10 domains of physical ability: respiratory function, cough, bed mobility, supine to sitting on the edge of the bed, dynamic sitting, sit to stand, standing balance, transferring from bed to chair, stepping and grip strength. The validation of the CPAX tools will focus on the validity of constructs, internal consistency reliability and test-retest reliability.	three days

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Physical Function in Intensive Care Test	The PFIT is a test that measures function status of patients with a variety of conditions in the ICU. It includes 5 items: amount of assistance for sit-to-stand transfers, strength for shoulder flexion, strength for knee extension, marching in place, and an upper extremity endurance task of arm elevation to 90 degrees of shoulder flexion. PFIT used for criterion validity.	three days

Collaborators and Investigators

• Sponsor: Saglik Bilimleri Universitesi
• Collaborators: Medical Park Hospital Istanbul
• Investigators: Study Director: Esra Pehlivan, Ass.Prof, Saglik Bilimleri Universitesi; Principal Investigator: Mehmet Burak Uyaroğlu, PT, MSc, Saglik Bilimleri Universitesi; Study Chair: Sümeyye Akcay, PT, MSc, Saglik Bilimleri Universitesi; Study Chair: Gamze Koyutürk, PT, MSc, Saglik Bilimleri Universitesi; Study Chair: Hakan Parlak, MD, Istinye University Bahcesehir Hospital; Study Chair: Kürsat Baydilli, PhD, Saglik Bilimleri Universitesi

Study record dates

Study Major Dates

• Study Start (Actual): January 11, 2021
• Primary Completion (Actual): January 11, 2021
• Study Completion (Actual): January 14, 2021

Study Registration Dates

• First Submitted: March 8, 2021
• First Submitted That Met QC Criteria: March 22, 2021
• First Posted (Actual): March 23, 2021

Study Record Updates

• Last Update Posted (Actual): August 23, 2023
• Last Update Submitted That Met QC Criteria: August 22, 2023
• Last Verified: August 1, 2023

More Information

Terms related to this study

• Keywords: Physical Function; Critical İll; ICU Acquired Weakness
• Additional Relevant MeSH Terms: Asthenia
• Other Study ID Numbers: Saglik Bilimleri University (Saglik Bilimleri University)

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No